Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Smarter, Better, Faster, Smaller: ASCO Pushes For Cancer Trial Improvements


Related Content

Cancer Trials Should Show Minimum 20% Overall Survival Benefit, ASCO Suggests
Untargeting Xalkori? Hints Of Efficacy In ALK-Negative Patients Must Be Addressed, FDA Says
Time Is Right For Patient-Centered Approach To Health Care Because Current Way “Is Not Working” – FDA’s Hamburg
Industry Presses FDA For More Specificity On Lung Cancer Study Endpoints
FDA Biomedical Innovation Initiative Draws On Familiar Themes
PCORI Following Intent Of Legislators, But Needs To Be Careful In Defining “Patient-Centered Outcomes Research” – Former Senate Staffer
Quality-Of-Life Data Take On Added Significance With Avastin Debate
Beyond The Guidance: The Business Of Co-Development Combinations
Phase II Proof Of Concept Study Design Options For Co-developed Drugs
In A First, Merck And AstraZeneca Team Up For Oncology Study

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts